Symbol="BMRN"
AssetType="Common Stock"
Name="Biomarin Pharmaceutical Inc"
Description="BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California."
CIK="1048477"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="105 DIGITAL DRIVE, NOVATO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="16590891000"
EBITDA="195456000"
PERatio="238.89"
PEGRatio="0.643"
BookValue="25.42"
DividendPerShare="0"
DividendYield="0"
EPS="0.37"
RevenuePerShareTTM="11.98"
ProfitMargin="0.0447"
OperatingMarginTTM="0.0422"
ReturnOnAssetsTTM="0.0093"
ReturnOnEquityTTM="0.0215"
RevenueTTM="2234572000"
GrossProfitTTM="1612370000"
DilutedEPSTTM="0.37"
QuarterlyEarningsGrowthYOY="0.942"
QuarterlyRevenueGrowthYOY="0.115"
AnalystTargetPrice="116.52"
TrailingPE="238.89"
ForwardPE="31.25"
PriceToSalesRatioTTM="10.05"
PriceToBookRatio="4.409"
EVToRevenue="9.94"
EVToEBITDA="90.91"
Beta="0.366"
num_52WeekHigh="117.77"
num_52WeekLow="80.53"
num_50DayMovingAverage="89.65"
num_200DayMovingAverage="96.44"
SharesOutstanding="187701000"
DividendDate="None"
ExDividendDate="None"
symbol="BMRN"
open="88.37"
high="88.54"
low="87.69"
price="87.74"
volume="1095402.00"
latest_trading_day="2023-08-03"
previous_close="88.39"
change="-0.65"
change_percent="-0.7354%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="1241381"
Change_recent_avg="-0.07"
Delta_recent_avg="2.06"
Variance_recent_avg="1.03"
Change_ratio_recent_avg="-0.09"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="141"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0035.jpeg"
image_negative_thumbnail_id_2="155"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0021.jpeg"
image_neutral_thumbnail_id_1="566"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_neutral_thumbnail_id_2="552"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_positive_thumbnail_id_1="1166"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_positive_thumbnail_id_2="1006"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0168.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
